GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (TSX:BLCO) » Definitions » Accumulated other comprehensive income (loss)

Bausch & Lomb (TSX:BLCO) Accumulated other comprehensive income (loss) : C$-1,872 Mil (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Bausch & Lomb's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2025 was C$-1,872 Mil.

Bausch & Lomb's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2024 (C$-1,691 Mil) to Dec. 2024 (C$-1,973 Mil) but then increased from Dec. 2024 (C$-1,973 Mil) to Mar. 2025 (C$-1,872 Mil).

Bausch & Lomb's annual Accumulated other comprehensive income (loss) increased from Dec. 2022 (C$-1,709 Mil) to Dec. 2023 (C$-1,670 Mil) but then declined from Dec. 2023 (C$-1,670 Mil) to Dec. 2024 (C$-1,973 Mil).


Bausch & Lomb Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Bausch & Lomb's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb Accumulated other comprehensive income (loss) Chart

Bausch & Lomb Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial -1,138.72 -1,324.80 -1,708.99 -1,670.29 -1,973.21

Bausch & Lomb Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,736.67 -1,789.87 -1,690.54 -1,973.21 -1,872.02

Bausch & Lomb Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


Bausch & Lomb Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch & Lomb Business Description

Industry
Traded in Other Exchanges
Address
520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Executives
Ambrose Robert Douglas Bailey Senior Officer
Andrew Jude Stewart Senior Officer